The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Open accessAbstract
Plasma xanthine oxidase (XO) activity was defined as a source of enhanced vascular superoxide (O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} ) and hydrogen peroxide (H 2 O 2 ) production in both sickle cell disease (SCD) patients and knockout-transgenic SCD mice. There was a significant increase in the plasma XO activity of SCD patients that was similarly reflected in the SCD mouse model. Western blot and enzymatic analysis of liver tissue from SCD mice revealed decreased XO content. Hematoxylin and eosin staining of liver tissue of knockout-transgenic SCD mice indicated extensive hepatocellular injury that was accompanied by increased plasma content of the liver enzyme alanine aminotransferase. Immunocytochemical and enzymatic analysis of XO in thoracic aorta and liver tissue of SCD mice showed increased vessel wall and decreased liver XO, with XO concentrated on and in vascular luminal cells. Steady-state rates of vascular O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} production, as indicated by coelenterazine chemiluminescence, were significantly increased, and nitric oxide ( ⋅ NO)-dependent vasorelaxation of aortic ring segments was severely impaired in SCD mice, implying oxidative inactivation of ⋅ NO. Pretreatment of aortic vessels with the superoxide dismutase mimetic manganese 5,10,15,20-tetrakis( N -ethylpyridinium-2-yl)porphyrin markedly decreased O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} levels and significantly restored acetylcholine-dependent relaxation, whereas catalase had no effect. These data reveal that episodes of intrahepatic hypoxia-reoxygenation associated with SCD can induce the release of XO into the circulation from the liver. This circulating XO can then bind avidly to vessel luminal cells and impair vascular function by creating an oxidative milieu and catalytically consuming ⋅ NO via O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} -dependent mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding of plasma XO to ECs can lead to vascular dysfunction (45, 71, 562, 612, 1010).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Self-citationRed Cell Metabolism: A Manual of Biochemical Methods.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-6-985_1 · Cited by 2,327
Radí, R., Beckman, J. S., Bush, K. M., & Freeman, B. Α. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,201
Self-citationRubbo, H., Radí, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., KIRK, M. C., & Freeman, B. Α. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47160-8 · Cited by 1,350
Self-citationFormation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite
van der Vliet, A., Eiserich, J. P., Halliwell, B., & Cross, C. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7617 · Cited by 780
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
Superoxide and peroxynitrite inatherosclerosis.
White, C. R., Brock, T. A., Chang, L. Y., Crapo, J. D., BRISCOE, P. M., Ku, D. D., Bradley, W. A., Gianturco, S. H., Gore, J. Z., & Freeman, B. Α. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1044 · Cited by 684
Self-citationKissner, R., Nauser, T., Bugnon, P., Lye, P. G., & Koppenol, W. H. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970160x · Cited by 629
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Butler, R., Morris, A. D., Belch, J. J. F., Hill, A., & Struthers, A. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.746 · Cited by 463
Spontaneous oxygen radical generation by sickle erythrocytes.
Hebbel, R. P., Eaton, J. W., Balasingam, M., & Steinberg, M. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110724 · Cited by 444
Flagged first, then by citations
Research works printed but not linked: 8
- 10.1182/blood.V94.5.1555 · DOI
- C O Enwonwu Med Sci Res 17, 997–998 (1989).
- C R Morris, F A Kuypers, S Larkin, N Sweeters, J Simon, E P Vichinsky, L A Styles Br J Haematol 111, 498–500 (2000).
- S Giler, O Sperling, S Brosh, I Urca, A De Vries Isr J Med Sci 11, 1225 (1975).
- K Wolko, J Krawczynski Mater Med Pol 6, 95–98 (1974).
- D A Parks, D N Granger Am J Physiol 245, G285–G289 (1983).
- Y Yokoyama, J S Beckman, T K Beckman, J K Wheat, T G Cash, B A Freeman, D A Parks Am J Physiol 258, G564–G570 (1990).
- E A Kowaluk, P Seth, H L Fung J Pharmacol Exp Ther 262, 916–922 (1992).
Cited by
Sorted by citations
Items 201–300 of 391
Krajewski, M. L., Hsu, L. L.-Y., & Gladwin, M. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2008 · Cited by 28
Self-citationNguyen, V. T., Nassar, D., Batteux, F., Raymond, K., Tharaux, P., & Aractingi, S. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.005 · Cited by 30
Sickle cell disease as a vascular disorder
Ofori-Acquah, S. F. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1758555 · Cited by 28
Burrage, E. N., Coblentz, T., Prabhu, S. S., Childers, R., Bryner, R. W., Lewis, S. E., DeVallance, E., Kelley, E. E., & Chantler, P. D. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231152551 · Cited by 28
Badaki‐Makun, O., Scott, J. P., Panepinto, J. A., Casper, T. C., Hillery, C. A., Dean, J. M., & Brousseau, D. C. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24925 · Cited by 27
Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide
van der Veen, R. C., Dietlin, T. A., Karapetian, A., Holland, S. M., & Hofman, F. M. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.05.008 · Cited by 26
Evolving treatment paradigms in sickle cell disease
Jagadeeswaran, R., & Rivers, A. E. (2017) · Hematology · doi:10.1182/asheducation-2017.1.440 · Cited by 26
Kelley, E. E. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1523-8 · Cited by 30
Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction
Nader, É., Conran, N., Romana, M., & Connes, P. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200024 · Cited by 35
Swartz, H. M., Mason, R. P., Hogg, N., Kalyanaraman, B., Sarna, T., Plonka, P. M., Zareb, M., Gutiérrez, P. L., & Berliner, L. J. (2005) · Biological magnetic resonance · doi:10.1007/0-387-26741-7_3 · Cited by 27
Mehmood, A., Zhao, L., Wang, C., Hossen, I., Raka, R. N., & Zhang, H. (2020) · Food & Function · doi:10.1039/d0fo90011g · Cited by 25
Rogers, N. M., Yao, M., Sembrat, J., George, M. P., Knupp, H. E., Ross, M., Sharifi‐Sanjani, M., Milošević, J., Croix, C. M. S., Rajkumar, R., et al. (2013) · Pulmonary Circulation · doi:10.1086/674754 · Cited by 25
Self-citationXanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease
Schmidt, H. M., Wood, K. C., Lewis, S. E., Hahn, S. A., Williams, X. M., McMahon, B., Baust, J., Yuan, S. S., Bachman, T. N., Wang, Y., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315081 · Cited by 24
Self-citationEndothelial dysfunction in patients with ulcerative colitis
Kocaman, O., Şahı̇n, T., Aygün, C., Şentürk, Ö., & Hülagü, S. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000217764.88980.74 · Cited by 24
Pavitra, E., Acharya, R. K., Gupta, V. K., Verma, H. K., Kang, H., Lee, J., Sahu, T. A., Bhaskar, L. V., Raju, G. S. R., & Huh, Y. S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116849 · Cited by 24
Stivala, S., Gobbato, S., Bonetti, N. R., Camici, G. G., Lüscher, T. F., & Beer, J. H. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15581 · Cited by 23
Kaul, D. K., Fabry, M. E., Suzuka, S. M., & Zhang, X. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00296.2012 · Cited by 22
Möckesch, B., Charlot, K., Jumet, S., Romana, M., Divialle‐Doumdo, L., Hardy‐Dessources, M., Petras, M., Tressières, B., Tarer, V., Hüe, O., et al. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.02.001 · Cited by 24
cGMP modulation therapeutics for sickle cell disease
Conran, N., & Torres, L. S. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219827276 · Cited by 23
Thamilarasan, M., Estupinan, R., Batinic̈‐Haberle, I., & Zennadi, R. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001642 · Cited by 23
Self-citationSopko, N. A., Matsui, H., Hannan, J. L., Berkowitz, D. E., Champion, H. C., Hsu, L. L.-Y., Musicki, B., Burnett, A. L. “., & Bivalacqua, T. J. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12976 · Cited by 23
Therapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction
Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-45805-1_13 · Cited by 32
Self-citationNader, É., Garnier, Y., Connes, P., & Romana, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.728693 · Cited by 23
Oxidative stress in sickle cell disease; more than a DAMP squib
van Beers, E. J., & van Wijk, R. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189010 · Cited by 23
Mechanisms and Clinical Complications of Hemolysis in Sickle Cell Disease and Thalassemia
Kato, G. J., & Gladwin, M. T. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.016 · Cited by 22
Self-citationUrease enhances the formation of iron nitrosyl hemoglobin in the presence of hydroxyurea
Lockamy, V. L., Huang, J., Shields, H. W., Ballas, S. K., King, S. B., & Kim‐Shapiro, D. B. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00132-6 · Cited by 23
The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease
Küpesiz, A., Çelmeli, G., Doğan, S., Antmen, B., & Aslan, M. (2012) · Free Radical Research · doi:10.3109/10715762.2012.686037 · Cited by 21
Self-citationThe Clinical Application of Ozonetherapy
Bocci, V. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9234-2_9 · Cited by 24
Hydroxyurea and Sickle Cell Disease
Weiner, D. L., & Brugnara, C. (2003) · JAMA · doi:10.1001/jama.289.13.1692 · Cited by 21
Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease
Gorbach, A. M., Ackerman, H. C., Liu, W., Meyer, J., Littel, P. L., Seamon, C. A., Footman, E., Chi, A., Zorca, S. M., Krajewski, M. L., et al. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.06.011 · Cited by 20
Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach
Fox, B. M., & Kasztan, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.04.001 · Cited by 20
Moralez, G., Jouett, N., Tian, J., Zimmerman, M. C., Bhella, P. S., & Raven, P. B. (2018) · The Journal of Physiology · doi:10.1113/jp274697 · Cited by 20
Detterich, J. A., Liu, H., Suriany, S., Kato, R. M., Chalacheva, P., Tedla, B. A., Shah, P., Khoo, M. C. K., Wood, J. C., Coates, T. D., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.07.004 · Cited by 20
Self-citationTotal Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease
Antwi‐Boasiako, C., Kusi-Mensah, Y. A., Hayfron-Benjamin, C. F., Aryee, R., Dankwah, G. B., Abla, K. L., & Darkwa, E. O. (2019) · Medicina · doi:10.3390/medicina55090547 · Cited by 20
Almeida, L. E. F., Kamimura, S., Batista, C. M. D. S., Spornick, N., Nettleton, M. Y., Walek, E., Smith, M. L., Finkel, J. C., Darbari, D. S., Wakim, P., et al. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.10.011 · Cited by 20
Effects of a Single Sickling Event on the Mechanical Fragility of Sickle Cell Trait Erythrocytes
Presley, T. D., Perlegas, A. S., Bain, L. E., Ballas, S. K., Nichols, J. S., Sabio, H., Gladwin, M. T., Kato, G. J., & Kim‐Shapiro, D. B. (2010) · Hemoglobin · doi:10.3109/03630260903546999 · Cited by 22
Self-citationEndothelin in Renal Injury due to Sickle Cell Disease
Tharaux, P. (2011) · Contributions to nephrology · doi:10.1159/000328699 · Cited by 19
Kaul, D. K., Kollander, R., Mahaseth, H., Liu, X. D., Solovey, A. N., Belcher, J. D., Kelm, R. J., Vercellotti, G. M., & Hebbel, R. P. (2006) · Microcirculation · doi:10.1080/10739680600778456 · Cited by 19
DeVallance, E., Schmidt, H. M., Seman, M., Lewis, S. E., Wood, K. C., Vickers, S. D., Hahn, S. A., Velayutham, M., Hileman, E. A., Vitturi, D. A., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102866 · Cited by 20
Kotozaki, Y., Satoh, M., Nasu, T., Tanno, K., Tanaka, F., & Sasaki, M. (2023) · Biomedicines · doi:10.3390/biomedicines11030754 · Cited by 19
Lipoprotein Subfraction Profile and HDL‐Associated Enzymes in Sickle Cell Disease Patients
Öztürk, O. H., Can, Y., Yönden, Z., Motor, S., Oktay, G., Kaya, H., & Aslan, M. (2013) · Lipids · doi:10.1007/s11745-013-3849-4 · Cited by 17
Self-citationNitric oxide metabolism and the acute chest syndrome of sickle cell anemia
Sullivan, K., Kissoon, N. “., & Gauger, C. A. (2008) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181668ca9 · Cited by 17
Taibi, G., Carruba, G., Miceli, V., Cocciadiferro, L., Cucchiara, A., & Nicotra, C. M. A. (2009) · Free Radical Research · doi:10.3109/10715760903431426 · Cited by 17
Genistein ameliorates hyperuricemia-associated nephropathy in hyperuricemic mice
Bi, W., & Cailin, Z. (2021) · Food and Agricultural Immunology · doi:10.1080/09540105.2021.1996540 · Cited by 16
Schmidt, H. M., DeVallance, E., Lewis, S. E., Wood, K. C., Annarapu, G. K., Carreño, M., Hahn, S. A., Seman, M., Maxwell, B. A., Hileman, E. A., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102636 · Cited by 18
A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia
Hanson, M. S., Xu, H., Flewelen, T. C., Holzhauer, S., Retherford, D. M., Jones, D. W., Frei, A. C., Pritchard, K. A., Hillery, C. A., Hogg, N., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00500.2012 · Cited by 16
Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo
McMahon, T. J., Shan, S., Riccio, D. A., Batchvarova, M., Zhu, H., Telen, M. J., & Zennadi, R. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019031633 · Cited by 17
Ji, X., Xu, H., Zhang, H., Hillery, C. A., Gao, H., & Pritchard, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091089 · Cited by 15
Lewis, S. E., Rosencrance, C. B., DeVallance, E., Giromini, A. P., Williams, X. M., Oh, J., Schmidt, H. M., Straub, A. C., Chantler, P. D., Patel, R. P., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.012 · Cited by 19
Self-citationNeutrophil oxidative metabolism in Down syndrome patients with congenital heart defects
Akıncı, Ö., Mıhçı, E., Taçoy, Ş., Kardelen, F., Keser, İ., & Aslan, M. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20511 · Cited by 15
Self-citationFunctional consequences of actin nitration: in vitro and in disease states
Aslan, M. (2010) · Amino Acids · doi:10.1007/s00726-010-0613-4 · Cited by 15
Self-citationDoğan, S., Elpek, G. Ö., Konuk, E., Demir, N., & Aslan, M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.028 · Cited by 15
Self-citationSaudi guidelines on diagnosis and treatment of pulmonary arterial hypertension
Majdy, I., Al-Hajjaj, M. S., Javeed, K., Manal, A.-H., Alanezi, M. O., Saleemi, S., Sanai, F. M., Kashour, T. S., Wali, S., & Barst, R. J. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 14
Pereira, D. A., Calmasini, F. B., Costa, F. F., Burnett, A. L. “., & Silva, F. H. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001962 · Cited by 16
Rivers, A. E., Jagadeeswaran, R., & Lavelle, D. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00440.2017 · Cited by 14
Non-invasive detection of endothelial dysfunction in sickle cell disease by Doppler ultrasonography.
Zawar, S. D., Vyawahare, M., Nerkar, M., & Jawahirani, A. R. (2005) · PubMed · Cited by 14
Arginine Therapy for Pain in Sickle Cell Disease: A Phase‐2 Randomized, Placebo‐Controlled Trial
Morris, C. R., Hatabah, D., Korman, R., Gillespie, S. E., Bakshi, N., Brown, L. A. S., Harris, F. L., Leake, D., Rees, C. A., Khemani, K., et al. (2025) · American Journal of Hematology · doi:10.1002/ajh.27692 · Cited by 13
Upadhya, B., Stacey, R. B., Ntim, W. O., Knovich, M. A., & Pu, M. (2014) · Acta Haematologica · doi:10.1159/000357393 · Cited by 13
Alkindi, S. S. A., Almufargi, S. S., & Pathare, A. V. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219892846 · Cited by 13
CoenzymeQ in cellular redox regulation and clinical heart failure
Yuan, S. S., Schmidt, H. M., Wood, K. C., & Straub, A. C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.011 · Cited by 16
Barbosa, M. C., dos Santos, T. E. D. J., dos Santos, T. N., Pedrosa, A. M., Elias, D. B. D., Leal, L. K. A. M., Lopes, A. D. A., Sasahara, G. L., & Lemes, R. P. G. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12487 · Cited by 13
Blood feud: Keeping hemoglobin from nixing NO
Liao, J. C. (2002) · Nature Medicine · doi:10.1038/nm1202-1350 · Cited by 13
Nitrergic Mechanisms for Management of Recurrent Priapism
Anele, U. A., & Burnett, A. L. “. (2015) · Sexual Medicine Reviews · doi:10.1002/smrj.56 · Cited by 12
L ‐Arginine inhibits xanthine oxidase‐dependent endothelial dysfunction in hypercholesterolemia
White, C. R., Parks, D. A., Patel, R. P., Shelton, J. E., Tarpey, M. M., Freeman, B. Α., & Darley-Usmar, V. M. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00137-1 · Cited by 12
Self-citationYeh, G. C., Henderson, J. P., Byun, J., d’Avignon, D. A., & Heinecke, J. W. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00256-x · Cited by 12
Lockamy, V. L., Shields, H. W., Kim‐Shapiro, D. B., & KING, S. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.07.003 · Cited by 12
White, C. W. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.008 · Cited by 12
Self-citationBrain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease
Cui, M., Suzuka, S. M., Branch, N. A., Ambadipudi, K., Thangaswamy, S., Acharya, S. A., Billett, H. H., & Branch, C. A. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3692 · Cited by 11
Vinhaes, C. L., Teixeira, R., Monteiro-Júnior, J. A. S., Tibúrcio, R., Cubillos-Angulo, J. M., Arriaga, M. B., Sabarin, A. G., de Souza, A. J., Silva, J. J., Lyra, I. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76075-5 · Cited by 11
MEK1/2 as a Therapeutic Target in Sickle Cell Disease
Zennadi, R. (2019) · International Journal of Blood Research and Disorders · doi:10.23937/2469-5696/1410038 · Cited by 10
Asthma Management in Sickle Cell Disease
Gomez, E., & Morris, C. R. (2013) · BioMed Research International · doi:10.1155/2013/604140 · Cited by 12
Reaping of nitric oxide by sickle cell disease
Lancaster, J. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032633399 · Cited by 11
Shilo, N. R., & Morris, C. R. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1364989 · Cited by 12
Crosstalk Between Sickle Cell Disease and Ferroptosis
Russo, A., Patanè, G. T., Calderaro, A., Barreca, D., Tellone, E., & Putaggio, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083675 · Cited by 11
Rivell, G. L., Brunson, C. Y., Milligan, L., Stuart, R. K., & Costa, L. J. (2011) · American Journal of Hematology · doi:10.1002/ajh.22054 · Cited by 10
Long-term oxygen therapy in children with sickle cell disease and hypoxaemia
Liguoro, I., Arigliani, M., Singh, B., Rees, D. C., Inusa, B. P. D., & Gupta, A. K. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-319347 · Cited by 10
Role of xanthine oxidoreductase in the anti-thrombotic effects of nitrite in ratsin vivo
Kramkowski, K., Leszczynska, A., Przyborowski, K., Kaminski, T. W., Rykaczewska, U., Sitek, B., Zakrzewska, A., Proniewski, B., Smolenski, R. T., Chabielska, E., et al. (2015) · Platelets · doi:10.3109/09537104.2015.1083545 · Cited by 11
Recent trends in pulmonary arterial hypertension
Natarajan, R. (2011) · Lung India · doi:10.4103/0970-2113.76300 · Cited by 10
T cell expansion is regulated by activated Gr-1+ splenocytes
Dietlin, T. A., Hofman, F. M., Gilmore, W., Stohlman, S. A., & van der Veen, R. C. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.06.008 · Cited by 10
Decrease in lung nitric oxide production after peritonitis in mice with sickle cell disease*
Bartolucci, P., Ngo, M., Beuzard, Y., Galactéros, F., Saber, G., Rideau, D., Eddahibi, S., Maître, B., Adnot, S., & Delclaux, C. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000253403.65602.ea · Cited by 10
Level of nitric oxide and antioxidant vitamins in sickle cell anaemia patients.
Hundekar, P. S., Suryakar, A. N., Karnik, A., Katkam, R., Joshi, N. G., & Ghone, R. A. (2012) · PubMed · Cited by 10
Lin, E. E., Gladwin, M. T., & Machado, R. F. (2005) · PubMed · Cited by 10
Self-citationAyoola, O. O., Bolarinwa, R. A., Onwuka, C. C., Idowu, B. M., & Aderibigbe, A. S. (2020) · Kidney360 · doi:10.34067/kid.0000142019 · Cited by 9
Heme on Pulmonary Malaria: Friend or Foe?
Pádua, T. A., & de Souza, M. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01835 · Cited by 9
Dony, C., Illipparambil, L. C., Maeda, T., Mroczek, S., Rovitelli, A., Wexler, O., Malnoske, M., Bice, T., Fe, A. Z., Storms, C. R., et al. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000006006 · Cited by 9
Liang, Q., Huan, S., Lin, Y., Su, Z., Yao, X., Li, C., Ji, Z., & Zhang, X. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103340 · Cited by 10
Kalmár, J., Biri, B., Lente, G., Bányai, I., Budimir, A., Biruš, M., Batinic̈‐Haberle, I., & Fábián, I. (2012) · Dalton Transactions · doi:10.1039/c2dt31200j · Cited by 9
Self-citationInflammation and Sickle Cell Anemia
Almeida, C. B., Kato, G. J., & Conran, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_8 · Cited by 9
Rivera, C. P., Li, L., Cai, S., Pei, N., McAlear, G. E., Bollavaram, K., Ariyo, O. V., Omojola, V. O., Song, H. W., Alfonso, A. L., et al. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102486 · Cited by 9
Morris, C. R. (2010) · The Open Nitric Oxide Journal · doi:10.2174/1875042701002020041 · Cited by 9
Cho, Y. S., Choi, J. H., Zhang, S. Y., Lee, J. H., Hwang, K., Kim, H. S., Oh, B., Lee, M. M., Park, Y. B., & Choi, Y. S. (2003) · Korean Circulation Journal · doi:10.4070/kcj.2003.33.2.104 · Cited by 9
Oxidases and oxygenases in regulation of neutrophil redox pathways in Behçet’s disease patients
Melikoğlu, M. A., Kaçar, C., Çört, A., Yücel, G., & Aslan, M. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.572281 · Cited by 9
Self-citationThe vaso-occlusive pain crisis in sickle cell patients: A focus on pathogenesis
Javaherforooshzadeh, F., Fateh, A., Saffari, H., Khodadadi, M., Samarin, M. E., Nikoubakht, N., Dadgar, F., & Goodarzi, V. (2025) · Current Research in Translational Medicine · doi:10.1016/j.retram.2025.103512 · Cited by 12
Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction
Nader, É., Conran, N., Romana, M., & Connes, P. (2021) · Comprehensive physiology · doi:10.1002/j.2040-4603.2021.tb00164.x · Cited by 8
Karafin, M. S., Field, J. J., Ilich, A., Li, L., Qaquish, B., Shevkoplyas, S. S., & Yoshida, T. (2022) · Transfusion · doi:10.1111/trf.17163 · Cited by 8
Vilas-Boas, W., Figueiredo, C. V. B., Pitanga, T. N., Carvalho, M. O. S., Santiago, R. P., Santana, S. S., da Guarda, C. C., Zanette, Â., Cerqueira, B. A. V., & Gonçalves, M. D. S. (2016) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s38276 · Cited by 8
Antioxidants, Radical Scavengers, and Their Impact on Oxidative Stress
Ohiagu, F. O., Chikezie, P. C., Maduka, T. O., Chikezie, C. M., Nwaiwu, O., & Paudel, K. R. (2025) · Free Radicals and Antioxidants · doi:10.5530/fra.2024.2.7 · Cited by 11
Sun, C. W., Willmon, C. L., Wu, L.-C., Knopick, P. L., Thoerner, J., Vile, R. G., Townes, T. M., & Terman, D. S. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00166 · Cited by 7
Self-citationKelley, E. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_4 · Cited by 7
Dioxygen-Dependent Metabolism of Nitric Oxide
Gardner, P. R., Gardner, A. M., & Hallstrom, C. K. (2004) · Humana Press eBooks · doi:10.1385/1-59259-807-2:133 · Cited by 7
Metadata
- Authors
- Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., Batinic-Haberle, I., White, C. R., & Freeman, B. A.
- Affiliations
- National Institutes of Health (US)
- Departments of Anesthesiology, Biochemistry and Molecular Genetics, Pathology, Medicine, and Surgery, Center for Free Radical Biology, Imaging Facility and Comprehensive Sickle Cell Disease Center, University of Alabama, Birmingham, AL 35233; Critical Care Medicine Department of the Warren G. Magnuson Clinical Center, and Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; and Department of...
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 98
- Issue
- 26
- Pages
- 15215-15220
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC65009
- OpenAlex
- W2014093734
- Cited by
- 391
- References
- 67
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 12 · 2022: 9 · 2021: 14 · 2020: 14 · 2019: 18 · 2018: 15 · 2017: 14 · 2016: 9 · 2015: 17 · 2014: 17 · 2013: 16 · 2012: 11
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p60hl058418-05)
- National Heart, Lung, and Blood Institute (R01HL64937, R01HL064937, P6-HL-58418, R01HL058115, R01-HL-58115)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- sickle cell disease, xanthine oxidase, superoxide, nitric oxide, hydrogen peroxide, hepatocyte injury, aorta, superoxide dismutase mimetic, manganese porphyrin
- MeSH terms
- Alanine Transaminase, Anemia, Sickle Cell, Animals, Endothelium, Vascular, Erythrocytes, Humans, Muscle Relaxation, Nitric Oxide, Superoxides, Xanthine Oxidase, Mice, Knockout, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review